Abstract
The objective of the present study was to formulate bilayer matrix tablets containing aceclofenac as sustained release and paracetamol as immediate release using HPMC as the matrix forming polymer and the tablets were evaluated via in-vitro studies. In-vitro drug release studies were carried out in hydrochloric acid buffer of pH 1.2 (0.1N) with 1% w/v SLS using USP paddle apparatus. The amount of drugs released at different time intervals were determined by validated UPLC-PDA method. In-vitro drug release from prepared tablets showed better effect when compared with marketed combination tablets. Tablets thus formulated provided sustained release of aceclofenac over a period of 12 h and paracetamol as immediate release within 30 min.
Keywords: Aceclofenac, bilayer tablet, immediate release, paracetamol, sustained release.
Drug Delivery Letters
Title:Formulation and in-vitro Evaluation of a Bilayer Matrix Tablet Containing Aceclofenac as Sustained Release and Paracetamol as Immediate Release
Volume: 4 Issue: 3
Author(s): Hamid Khan and Javed Ali
Affiliation:
Keywords: Aceclofenac, bilayer tablet, immediate release, paracetamol, sustained release.
Abstract: The objective of the present study was to formulate bilayer matrix tablets containing aceclofenac as sustained release and paracetamol as immediate release using HPMC as the matrix forming polymer and the tablets were evaluated via in-vitro studies. In-vitro drug release studies were carried out in hydrochloric acid buffer of pH 1.2 (0.1N) with 1% w/v SLS using USP paddle apparatus. The amount of drugs released at different time intervals were determined by validated UPLC-PDA method. In-vitro drug release from prepared tablets showed better effect when compared with marketed combination tablets. Tablets thus formulated provided sustained release of aceclofenac over a period of 12 h and paracetamol as immediate release within 30 min.
Export Options
About this article
Cite this article as:
Khan Hamid and Ali Javed, Formulation and in-vitro Evaluation of a Bilayer Matrix Tablet Containing Aceclofenac as Sustained Release and Paracetamol as Immediate Release, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/2210303104666140909004155
DOI https://dx.doi.org/10.2174/2210303104666140909004155 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Monoclonal Antibodies as Innovative Therapeutics
Current Pharmaceutical Biotechnology Biologics and the Cardiovascular System: A Double-Edged Sword
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
Current Medicinal Chemistry Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Current and Future Applications of Probiotics
Current Nutrition & Food Science Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Current Genomics Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
Current Drug Safety Editorial [Hot topic: Ocular Immunology (Guest Editor: Gerhild Wildner)]
Current Immunology Reviews (Discontinued) Cellular Mechanisms that Edit the Immunopeptidome
Current Proteomics The Effects of TNF α Antagonist Therapy on Bone Metabolism in Rheumatoid Arthritis: A Systematic Review
Current Drug Targets Detection of Damaging nsSNPs on Human Caspase-Cascades Related to Apoptotic Signalling Pathway
Protein & Peptide Letters Molecularly Imprinted Sol-Gel Materials for Medical Applications
Current Topics in Medicinal Chemistry Cryofibrinogenemia: What Rheumatologists Should Know
Current Rheumatology Reviews Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
Clinical Cancer Drugs The Molecular Functions of Nod Proteins and their Associated Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents